Steven Jungles

Brammer Bio LLC manufactures pharmaceutical products. The firm’s services include process development, gene therapy manaufacturing and viral vectors. The company was founded by Christopher K. Murphy, Richard O. Snyder, Mark R. Bamforth and Steven H. Kasok in 2015 and is headquartered in Cambridge, MA.

Somatix Therapy Corp. researches, develops, and commercialize proprietary processes for the genetic modification of cells and their use in the treatment of human disease. Somatix's assets include its highly efficient gene transfer technology, broad-based intellectual property, and focused product development programs. The company's most advanced clinical development program, the GVAX cancer vaccine, is in Phase I/II clinical trials for the treatment of metastatic renal cell carcinoma, advanced melanoma, and prostate cancer. It is located in Alameda, CA

Brammer Biopharmaceuticals LLC provides contract development and manufacturing services. Its services include process development, gene therapy and cell therapy manufacturing. The company was founded by Mark R. Bamforth and Steven H. Kasok in 2015 and is headquartered in Lexington, MA.